• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Site Map

Right Arrow Button IconLeft Arrow Button IconSitemap
Right Arrow Button IconLeft Arrow Button Icon2021
Right Arrow Button IconLeft Arrow Button IconDecember
Right Arrow Button Icon20
A Sinopharm booster generates ‘significantly lower’ levels of antibodies against Omicron, according to a new studyU.S. charges 5 Russian hackers for stealing and front-running earnings announcements from Tesla, Snap and othersOmicron now accounts for 73% of US COVID cases after spreading at lightning speedInvestors poured a record $30 billion into crypto in 2021How Mediahub built its metaverse office in just two days (and chose to rent, not buy)Student loan refinancing in 2022: How to do it, and what you should know firstIPO of men’s clothing brand Zegna shows luxury stocks are very much in fashionHow the CEOs of Apple, Nike, Citi, and more are pivoting their return-to-work plans in the wake of OmicronSchool closings rise as Omicron spreads across the U.S.A minuscule .01% of Bitcoin holders control nearly a third of the supply48 people test positive for COVID on Royal Caribbean cruiseEU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump sharesHome prices are set to soar in 2022, predicts ZillowSolarWinds tries to rebuild its reputation a year after its huge hack was discoveredBiden’s green orders seek to rebuild global trust on climateBangladesh Prime Minister: We rise from COVID-19 by helping the neediest firstRedfin just released its 10 hottest housing markets for 2022Biogen slashes cost of Alzheimer’s drug by 50% six months after FDA approvalSeven states including California, Florida and Georgia are sending out stimulus checks this monthWorld Economic Forum postpones January summit as the rise of Omicron stymies Davos yet againElon Musk fires back at critics: ‘I will pay over $11 billion in taxes this year’Moderna says its COVID-19 booster vaccine delivers a massive increase in antibodiesLockdowns spread across Europe in the face of Omicron’s ‘lightning’ advanceBooster shots are the best defense against Omicron. But a rush on extra jabs may make it harder to stop the rise of new variantsAccredited investor rules are perpetuating inequity‘Spider-Man: No Way Home’ has third-largest global opening despite not having a release date in the world’s largest film marketOmicron and Manchin deliver a one-two punch to global stock markets—crude, crypto, and equities plungeU.S. growth in jeopardy after Manchin says he won’t vote for Build Back Better: Goldman Sachs
CareersEntertainmentVenture CapitalCoronavirusAutosChinaMarketsThe Travel IndustryEnergyA.I.BitcoinFood and DrinkSportsLuxuryPoliticsEconomyCybersecurityReal EstateRussiaStartupsDiversity and InclusionElectionsInflationChief Executive Officer (CEO)InvestingEarningsSocial MediaTaxesClimate ChangeIPOsNetflixPharmaceutical IndustryFederal ReserveLaborMergers and AcquisitionsElectric VehiclesPrivate EquityCongressHousingUnemploymentRemote WorkBanksInterest RatesMental HealthLayoffsHuman ResourcesStudent Loans and DebtGen ZWealthNutrition
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.